ArticleExpert review of pharmacoeconomics & outcomes research2013
Hospitalizations for chronic obstructive pulmonary disease exacerbations and their impact on disease and subsequent morbidity and mortality.
Article in Expert review of pharmacoeconomics & outcomes research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Prevention of exacerbations in patients with COPD and vitamin D deficiency through vitamin D supplementation (PRECOVID): a study protocol.BMC pulmonary medicine · 2015Trial
- Development and Validation of Machine Learning-Based Models for Prediction of Intensive Care Unit Admission and In-Hospital Mortality in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.Chronic obstructive pulmonary diseases (Miami, Fla.) · 2024Article
- Age is a determinant of short-term mortality in patients hospitalized for an acute exacerbation of COPD.Internal and emergency medicine · 2021Observational
- Management of severe acute exacerbations of COPD: an updated narrative review.Multidisciplinary respiratory medicine · 2018Review
- Comparison of peak expiratory Flow(PEF) and COPD assessment test (CAT) to assess COPD exacerbation requiring hospitalization: A prospective observational study.Chronic respiratory diseaseObservational
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In chronic obstructive pulmonary disease (COPD), progressive airflow limitation is a risk factor for development of disease exacerbations, which, when severe, may require hospitalization. In the discussed study, a large cohort of patients hospitalized for their first COPD exacerbation were analyzed in terms of subsequent hospitalizations and mortality risk. COPD hospitalizations were found to be a risk factor for subsequent COPD-related hospitalizations, to increase their incidence and to increase the disease-related mortality risk. Male gender was also identified as a risk factor for a higher COPD-related morbidity and mortality. Hospitalizations for COPD exacerbation should be considered as additional criterion for disease severity in tailoring the disease management.
Identifiers
23570429What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.